Skip to main content
Erschienen in: Diabetologia 3/2003

01.03.2003 | Article

Effects of protein kinase C inhibition and activation on proliferation and apoptosis of bovine retinal pericytes

verfasst von: F. Pomero, A. Allione, E. Beltramo, S. Buttiglieri, F. D'Alù, E. Ponte, A. Lacaria, M. Porta, MD PhD

Erschienen in: Diabetologia | Ausgabe 3/2003

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Drop-out of capillary pericytes occurs early and selectively in diabetic retinopathy. High glucose concentrations decrease replication and increase apoptosis of cultured pericytes. Since glucose activates protein kinase C, we investigated the effects of modulating this intracellular mediator on replication, cell cycle and apoptosis of cultured bovine retinal pericytes.

Methods

Pericytes cultured in 5.6 or 28 mmol/l glucose were exposed to a protein kinase C activator (phorbol 12-myristate 13-acetate) and/or a selective inhibitor of its β2 isoform (LY379196). Cells were counted after 7 days. Proliferation by the tetrazolium to formazan assay and DNA synthesis by 5-bromo-2′-deoxyuridine incorporation were measured at day 4. Cell cycle by flow cytometry and apoptosis by ELISA were assessed at day 2.

Results

High glucose reduced pericyte replication and increased apoptosis. Protein kinase C activation increased proliferation, while inhibition of its β2 isoform decreased it. Cell cycle was accelerated by protein kinase C activation and delayed by inhibition. Apoptosis was enhanced by protein kinase C inhibition and reduced by activation.

Conclusions/interpretation

Protein kinase C inhibition amplifies the anti-proliferative and pro-apoptotic effects of high glucose on cultured pericytes, whereas stimulation reduces apoptosis and promotes proliferation both in physiological glucose and high glucose. Protein kinase C inhibition, proposed for the treatment of diabetic macular edema and proliferative retinopathy, might accelerate pericyte dropout in earlier stages when these cells are still present in retinal capillaries.
Literatur
1.
Zurück zum Zitat Cogan DG, Toussaint D, Kuwabara T (1961) Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol 66:366–378 Cogan DG, Toussaint D, Kuwabara T (1961) Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol 66:366–378
2.
Zurück zum Zitat Porta M, Molinatti PA, Dosso AA, Williams FM, Brooks RA, Kohner EM (1994) Growth of bovine retinal pericytes and endothelial cells in high hexose concentrations. Diabete Metab 20:25–30PubMed Porta M, Molinatti PA, Dosso AA, Williams FM, Brooks RA, Kohner EM (1994) Growth of bovine retinal pericytes and endothelial cells in high hexose concentrations. Diabete Metab 20:25–30PubMed
3.
Zurück zum Zitat Idris I, Gray S, Donnelly R (2001) Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 44:659–673CrossRefPubMed Idris I, Gray S, Donnelly R (2001) Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 44:659–673CrossRefPubMed
4.
Zurück zum Zitat Beltramo E, Pomero F, Allione A, D'Alu F, Ponte E, Porta M (2002) Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations. Diabetologia 45:416–419PubMed Beltramo E, Pomero F, Allione A, D'Alu F, Ponte E, Porta M (2002) Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations. Diabetologia 45:416–419PubMed
5.
Zurück zum Zitat Wolf BA, Williamson JR, Easom RA, Chang K, Sherman WR, Turk J (1991) Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest 87:31–38PubMed Wolf BA, Williamson JR, Easom RA, Chang K, Sherman WR, Turk J (1991) Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest 87:31–38PubMed
6.
Zurück zum Zitat Nishizuka Y (1986) Studies and perspectives of protein kinase C. Science 233:305–312PubMed Nishizuka Y (1986) Studies and perspectives of protein kinase C. Science 233:305–312PubMed
7.
Zurück zum Zitat Murray, NR, Thompson LJ, Fields AP (1997) The role of protein kinase C in cellular proliferation and cell cycle control. In: Parker PJ, Dekker L (eds) Molecular biology intelligence unit. Landes, Austin, pp 97–120 Murray, NR, Thompson LJ, Fields AP (1997) The role of protein kinase C in cellular proliferation and cell cycle control. In: Parker PJ, Dekker L (eds) Molecular biology intelligence unit. Landes, Austin, pp 97–120
8.
Zurück zum Zitat Xia P, Aiello LP, Ishii H et al. (1996) Characterization of vascular endothelial growth factor's effect on the activation of protein Kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98:2018–2026PubMed Xia P, Aiello LP, Ishii H et al. (1996) Characterization of vascular endothelial growth factor's effect on the activation of protein Kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98:2018–2026PubMed
9.
Zurück zum Zitat Lorenzi M, Gerhardinger C (2001) Early cellular and molecular changes induced by diabetes in the retina. Diabetologia 44:791–804CrossRef Lorenzi M, Gerhardinger C (2001) Early cellular and molecular changes induced by diabetes in the retina. Diabetologia 44:791–804CrossRef
10.
Zurück zum Zitat Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M (2002) Activation of nuclear factor-kappa B induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 51:2241–2248PubMed Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M (2002) Activation of nuclear factor-kappa B induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 51:2241–2248PubMed
Metadaten
Titel
Effects of protein kinase C inhibition and activation on proliferation and apoptosis of bovine retinal pericytes
verfasst von
F. Pomero
A. Allione
E. Beltramo
S. Buttiglieri
F. D'Alù
E. Ponte
A. Lacaria
M. Porta, MD PhD
Publikationsdatum
01.03.2003
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 3/2003
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-003-1044-5

Weitere Artikel der Ausgabe 3/2003

Diabetologia 3/2003 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.